Word

S

Status

Pending

Status Code

730

Status Date

Friday, November 10, 2023

Serial Number

97315301

Mark Type

3000

Filing Date

Wednesday, March 16, 2022

Published for Opposition

Tuesday, March 21, 2023

Trademark Owner History

Senda Biosciences, Inc. - Owner At Publication

Classifications

5 Therapeutic products in the nature of pharmaceuticals to modulate metabolism; pharmaceutical preparations and agents to modulate metabolism; therapeutic pharmaceuticals for the treatment of disease, namely, autoimmune diseases and disorders, bone and joint diseases and disorders, cancer, cardiovascular diseases and disorders, gastro-intestinal diseases and disorders, hematologic diseases and disorders, infectious diseases, kidney diseases and disorders, lung diseases and disorders, metabolic diseases and disorders, muscle diseases and disorders, nephrology diseases and disorders, neurodegenerative diseases and disorders, neurologic diseases and disorders, ophthalmic disease and disorders, skin diseases and disorders; pharmaceutical preparations for the treatment of disease, namely, autoimmune diseases and disorders, bone and joint diseases and disorders, cancer, cardiovascular diseases and disorders, gastro-intestinal diseases and disorders, hematologic diseases and disorders, infectious diseases, kidney diseases and disorders, lung diseases and disorders, metabolic diseases and disorders, muscle diseases and disorders, nephrology diseases and disorders, neurodegenerative diseases and disorders, neurologic diseases and disorders, ophthalmic disease and disorders, skin diseases and disorders; therapeutic pharmaceuticals for modulating metabolism; pharmaceutical agents that modulate metabolism for scientific and research use

42 Research and development in the field of computational biology, biotechnology and pharmaceuticals

The mark consists of a stylized "S".
SENDA
Color is not claimed as a feature of the mark.

Trademark Events

Nov 14, 2023

Notice Of Approval Of Extension Request E-Mailed

Nov 10, 2023

Sou Extension 1 Granted

Nov 10, 2023

Sou Extension 1 Filed

Nov 10, 2023

Sou Teas Extension Received

May 16, 2023

Noa E-Mailed - Sou Required From Applicant

Mar 21, 2023

Official Gazette Publication Confirmation E-Mailed

Mar 21, 2023

Published For Opposition

Mar 1, 2023

Notification Of Notice Of Publication E-Mailed

Feb 16, 2023

Approved For Pub - Principal Register

Feb 16, 2023

Examiner's Amendment Entered

Feb 16, 2023

Notification Of Examiners Amendment E-Mailed

Feb 16, 2023

Examiners Amendment E-Mailed

Feb 16, 2023

Examiners Amendment -Written

Jan 19, 2023

Teas/Email Correspondence Entered

Jan 19, 2023

Correspondence Received In Law Office

Jan 19, 2023

Teas Response To Office Action Received

Jan 9, 2023

Notification Of Non-Final Action E-Mailed

Jan 9, 2023

Non-Final Action E-Mailed

Jan 9, 2023

Non-Final Action Written

Dec 27, 2022

Assigned To Examiner

Mar 22, 2022

New Application Office Supplied Data Entered